Trial Details
COMPLETEDBasic Information
| Clinical ID | c737 |
|---|---|
| Identifier | NCT06126146 |
| Trial Title | An Observational Study to Assess Participant-Reported Real-World Experience of Risankizumab On-body Injector (OBI) for the Treatment of Crohn's Disease in Adult Participants in the United Kingdom (UK) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | - |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Hampshire |
| Country/Region | United Kingdom |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2023-10-26 |
|---|---|
| Primary Completion Date | 2024-05-16 |
| Completion Date | 2024-05-16 |